Mohammad A J Abdulla
Overview
Explore the profile of Mohammad A J Abdulla including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
40
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chronic Myeloid Leukemia in Adolescents and Young Adults: Clinicopathological Variables and Outcomes
Abdulla M, Aldapt M, Chandra P, El Akiki S, Alshurafa A, Nashwan A, et al.
Oncology
. 2024 Jul;
102(12):1018-1028.
PMID: 39013365
Introduction: Adolescents and young adults (AYAs) diagnosed with chronic myeloid leukemia (CML) constitute a significant demographic group, particularly in regions with youthful populations like Qatar. Despite the global median age...
2.
Yassin M, Soliman A, Hmissi S, Abdulla M, Itani M, Alamami A, et al.
Medicine (Baltimore)
. 2022 Sep;
101(36):e30431.
PMID: 36086749
Neutropenia ranges from a normal variant to life-threatening acquired and congenital disorders. This study aims at providing baseline information regarding the prevalence and spectrum of neutropenia in the Arab blood...
3.
Yassin M, Soliman A, Nashwan A, Alamami A, Abdulla M, Hmissi S, et al.
Medicine (Baltimore)
. 2022 Jun;
101(24):e29271.
PMID: 35713431
Hematologic reference intervals vary with gender, age, ethnicity, and geographic area. Therefore, local or national laboratory reference ranges are essential to enhance the accuracy when diagnosing health conditions. Still, no...
4.
Abdulla M, Chandra P, El Akiki S, Aldapt M, Sardar S, Chapra A, et al.
Cancer Control
. 2021 Nov;
28:10732748211038429.
PMID: 34789006
Objective: It is debatable whether BCR-ABL1 transcript type has an impact on outcome of treatment of patients with CML, and it is not widely studied whether body weight influences response...
5.
Al-Qudah B, Yassin M, Abdulla M, Aldapt M, Abufaied M
Case Rep Oncol
. 2020 Aug;
13(2):708-711.
PMID: 32774261
Chronic myeloid leukemia (CML) is a myeloproliferative neoplasm, classically described as a triphasic disease. However, little is known about risk factors for developing CML. Currently, ionizing radiation is the only...
6.
Ibrahim F, Abdulla M, Soliman D, Al Sabbagh A, Nawaz Z, Akiki S, et al.
Am J Case Rep
. 2020 May;
21:e923354.
PMID: 32398637
BACKGROUND Single or multiple cell line dysplasia is a characteristic feature of myelodysplastic syndrome. However, significant dysgranulopoiesis is not a feature of chronic myeloid leukemia (CML). Systemic mastocytosis (SM) with...
7.
Aldapt M, Soliman D, Szabados L, Sharaf Eldean M, Shwaylia H, Abdulla M, et al.
Am J Case Rep
. 2020 May;
21:e920411.
PMID: 32388531
BACKGROUND Most patients with chronic lymphocytic leukemia (CLL) are asymptomatic at diagnosis, but 10% present with B symptoms. Most patients have palpable lymphadenopathy, while 20-50% of the patients have hepatosplenomegaly....
8.
Yassin M, Soliman A, De Sanctis V, Hmissi S, Abdulla M, Ekeibed Y, et al.
Acta Biomed
. 2018 Apr;
89(3-S):18-22.
PMID: 29633728
Patients with hematologic malignancies undergoing chemotherapy and requiring blood transfusion usually have an elevated serum ferritin. These findings have led to the suggestion that iron overload is common and may...
9.
Abdulla M, Yassin M, Abdelrazek M, Mudawi D, Ibrahim F, Soliman D, et al.
Acta Biomed
. 2018 Feb;
89(2-S):41-46.
PMID: 29451228
Extramedullary hematopoiesis (EMH) is a rare disorder, defined as the appearance of hematopoietic elements outside the bone marrow or peripheral blood. The most common sites of EMH are liver and...